While approved anti-influenza drugs
are available, their effectiveness in the event of an influenza
pandemic may be limited due to drug resistance of the influenza
viruses. Elucidating the underlying mechanisms of the virus life
cycle and identifying new targets to be exploited for the discovery
of antiviral therapeutics are therefore paramount.